Dermoryx Urea 41% cream

Manufacturer
Oncora Pharma, LLC
Effective date
2026-10-28
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-11-03 06:11:59

Label at a glance#

ProductDermoyrx
Active ingredientUREA
Label structure8 sections

Dosage and administration

Apply Urea 41% to affected skin twice per day, or as directed by your physician. Rub in until completely absorbed. Apply to diseased or damaged nail(s) twice per day, or as directed by a physician.

Label contents#

Full prescribing information#

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eshar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

WARNINGS

WARNINGS SECTION

Avoid contact with eyes, lips and mucous membranes.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Discontinue use and consult a physician if redness or irritation occurs.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Apply Urea 41% to affected skin twice per day, or as directed by your physician. Rub in until completely absorbed.

Apply to diseased or damaged nail(s) twice per day, or as directed by a physician.

HOW SUPPLIED

HOW SUPPLIED SECTION

Dermoryx Urea 41% Cream 8 oz. (227 g): NDC 85477-910-30

STORAGE

SAFE HANDLING WARNING SECTION

Store at 20° to 25°C (68° to 77°F) [see USP Controlled
Room Temperature]. Protect from freezing and excessive
heat. Keep container tightly closed.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Dermoryx™

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

pdp
pdp

Distributed by

Oncora Pharma

Dallas, TX 75161

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130854770910300GTIN-13: 0854770910300
EAN-13: 0854770910300
GTIN-12: 854770910300
UPC-A: 854770910300
GTIN storage (14 digits): 00854770910300
dermoryx-1.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85477-91085477-910-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DermoyrxUREA 41%Oncora Pharma, LLCa92a9a6d-b4d1-4a1b-9331-91e3e00eddb02026-10-28Warnings, Adverse reactionsExact identifier
ndc (package): 85477-910-30
ndc (product): 85477-910
ndc11 (package): 85477091030
spl id: f2fc3898-f95b-46d9-85d6-ea620bf470bc
spl set id: a92a9a6d-b4d1-4a1b-9331-91e3e00eddb0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.